By: Marilyn McGoldrick, Esq. Published on September 9, 2015 NBC News has released the results of a year-long investigation into medical device manufacturer C.R. Bard and their “Recovery” blood clot filter. ┬áPart 1 of their report details the defects in the product; perhaps more shocking, Part 2 of their report asserts that C.R. Bard may… Read More

The FDA announced that it is requiring manufacturers of Low Testosterone (Low T) replacement products to add a warning to the product label of the risk of developing venous blood clots. Based on post-market reports of venous blood clots in the absence of polycythemia, the FDA will now require a general warning to men who use Low-T products that they may develop venous thromboembolism (VTE), including deep vein thrombosis (DVT), when venous blood clots form deep within the body, or pulmonary embolisms (PE), when those blood clots break off and travel towards the arteries in the lungs.… Read More